Full Text View
Tabular View
No Study Results Posted
Related Studies
Multidisciplinary Inpatient Palliative Care Intervention
This study has been completed.
First Received: May 12, 2006   No Changes Posted
Sponsors and Collaborators: Kaiser Permanente
Garfield Memorial Foundation
Information provided by: Kaiser Permanente
ClinicalTrials.gov Identifier: NCT00325611
  Purpose

Palliative care is believed to improve care of patients with life-limiting illnesses. This study evaluated the impact of a multi-center randomized trial of a palliative care team intervention on the quality and cost of care of hospitalized patients. Study subjects were randomized to intervention or usual care. At study end, patients receiving the palliative care intervention reported greater patient satisfaction with their care. Intervention patients also had significantly fewer ICU admissions and lower total costs for care 6 months past their hospitalization. Intervention patients completed more advance directives and had longer hospice stays.


Condition Intervention
Cerebrovascular Accident
Cancer
Coronary Arteriosclerosis
Heart Failure, Congestive
Diabetes Mellitus
Acquired Immunodeficiency Syndrome
Failure to Thrive
Pulmonary Disease, Chronic Obstructive
Dementia
Kidney Failure, Chronic
Pneumonia
Liver Failure
Renal Failure
Respiratory Failure
Stroke
Behavioral: Multidisciplinary palliative care team met with patient

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Placebo Control, Single Group Assignment
Official Title: A Multi-Site Replication of an Inpatient Palliative Care Program

Resource links provided by NLM:


Further study details as provided by Kaiser Permanente:

Primary Outcome Measures:
  • Quality and cost of care

Secondary Outcome Measures:
  • Greater patient satisfaction
  • Lower ICU admissions
  • Lower total costs 6 months past hospitalization

Estimated Enrollment: 550
Study Start Date: April 2002
Estimated Study Completion Date: July 2004
Detailed Description:

The Inpatient Palliative Care Service (IPCS) was implemented at three Kaiser-Permanente sites: Colorado, Portland and San Francisco. The service consisted of a physician, nurse, social worker, and spiritual counselor who worked with the study subjects randomized to receive the intervention. The intervention included symptom control, emotional and spiritual support, advance care and post-discharge care planning, There were no differences in symptom control or emotional support but IPCS patient reported better spiritual support compared to usual care patients. IPCS patients also reported greater satisfaction with their hospital care experience and better communication with their providers. Both IPCS and usual care patients reported improved quality of life during their enrollment hospital stay. IPCS patients completed more advance directives.

IPCS patients had more home health visits than usual care patients but significantly fewer ICU admissions. IPCS patients had significantly lower hospital costs and higher pharmacy costs, than the usual care patients. IPCS patients had significantly lower (p= .001) total health services costs (a cost savings of $64.90 per patient per day) compared to usual care patients. This translated to an average total cost savings of $3,185 per enrolled patient. IPCS patients had a significantly longer average hospice length of stay. There were no differences between IPC and usual care patients in the proportion admitted to hospice, time to hospice admission, the average length of survival, or proportion of those who survived to 6 months. Conclusion: IPCS resulted in better spiritual support, a better hospital care experience, better communication with their providers, increased completion of advance directives, fewer ICU admissions, longer hospice stays and reduced overall health care costs.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Adults 18 years and older

  • admitted to acute inpatient care who had: (1) a medical diagnosis which was life-threatening, and (2) whose attending physician indicated they “would not be surprised if the patient died within one year”.

Exclusion Criteria:

  • 1) they had impaired cognitive status and no caregiver was available to provide consent, (2) were currently enrolled in hospice or other studies involving palliative care, (3) the attending physician did not approve study participation, or (4) their medical condition impaired participation (actively dying, too ill to participate) and no family member was available to provide consent.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00325611

Locations
United States, Colorado
Kaiser Permanente of Colorado
Aurora, Colorado, United States, 80014
Sponsors and Collaborators
Kaiser Permanente
Garfield Memorial Foundation
Investigators
Study Director: Ingrid M Venohr, RN, PhD Kaiser Permanente
Principal Investigator: Douglas A Conner, PhD Kaiser Permanente Northwest Region
Principal Investigator: Marcia Liberson, MSW,MPH Kaiser-Permanente Northwest Region
  More Information

Publications:
Conner D, McGrady K, Richardson R, Beane J. Predictors of Hospice Admission and Length of Stay from a Randomized Control Trial of an Inpatient Palliative Care Service. Paper presentation at the American Academy of Hospice and Palliative Medicine annual meeting. February 2006, Nashville, TN.
McGrady K, Conner D, Richardson R, Beane J, Connors L, Rastrelli A, Collins T. Influence of an Inpatient Palliative Care Team on Service Utilization and Costs. Paper presentation at the American Academy of Hospice and Palliative Medicine annual meeting. February 2006, Nashville, TN.

Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):
Study ID Numbers: CO-02GGade-01 - H, NW-02RRich-01
Study First Received: May 12, 2006
Last Updated: May 12, 2006
ClinicalTrials.gov Identifier: NCT00325611     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Kaiser Permanente:
Palliative care
End of life care

Study placed in the following topic categories:
Liver Diseases
Cerebral Infarction
Arteriosclerosis
Brain Diseases
Respiratory Insufficiency
Kidney Diseases
Metabolic Disorder
Delirium
Arterial Occlusive Diseases
Heart Diseases
Metabolic Diseases
Respiration Disorders
Acquired Immunodeficiency Syndrome
Endocrine System Diseases
Ischemia
Cognition Disorders
Virus Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
HIV Infections
Lung Diseases
Growth Disorders
Infarction
Pneumonia
Sexually Transmitted Diseases, Viral
Renal Insufficiency
Myocardial Ischemia
Kidney Failure, Chronic
Cerebrovascular Disorders
Lung Diseases, Obstructive
Urologic Diseases

Additional relevant MeSH terms:
Liver Diseases
Slow Virus Diseases
Cerebral Infarction
Arteriosclerosis
Brain Diseases
Respiratory Insufficiency
Pathologic Processes
Cardiovascular Diseases
Kidney Diseases
Arterial Occlusive Diseases
Heart Diseases
Metabolic Diseases
Immune System Diseases
Respiration Disorders
Nervous System Diseases
Acquired Immunodeficiency Syndrome
Endocrine System Diseases
Virus Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
HIV Infections
Lung Diseases
Growth Disorders
Pneumonia
Sexually Transmitted Diseases, Viral
Disease Attributes
Renal Insufficiency
Myocardial Ischemia
Kidney Failure, Chronic
Cerebrovascular Disorders
Lung Diseases, Obstructive

ClinicalTrials.gov processed this record on September 01, 2009